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A. Hemoglobin and the hemoglobinopathies 
Hemoglobin
 Mature	red	blood	cells	 (RBC),	or	erythrocytes,	are	nucleus-free	cells	with	a	 life	span	
of	 approximately	 120	 days.	 In	 postnatal	 life,	 RBCs	 are	 produced	 in	 the	 bone	 marrow	 from	
multipotent	 stem	 cells	 under	 the	 influence	of	 different	 hematopoietic	 cytokines.	 They	 reside	
in	the	peripheral	blood	circulation	as	membrane-surrounded	flexible	bags	of	protein,	of	which	




(Figure	 1),	which	 form	a	 stable	 structure	 by	 strong	 hydrogen	bonding.	 Each	 chain	 contains	 a	
heme	group,	consisting	of	a	protoporphyrin	IX	ring	and	an	iron	atom	(Fe2+)	occupying	the	center	





protein	 consists	 of	 4	 subunits,	
each	 containing	 a	 heme	 group	
with	 an	 iron	 atom	 (Adapted	
from	 Michael	 W.	 King,	 PhD,	
themedicalbiochemistrypage.org,	
LLC).
Evolution of the globin gene clusters











later,	 the	 ancestral	 globin	 gene	 started	 to	 evolve	 through	 duplications,	mutations,	 deletions,	
gene	conversions	and	transpositions	events	into	the	current	globin	gene	clusters	(5;6).
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contain	 several	 other	 globin	 genes	 which	 are	 expressed	 at	 different	 stages	 of	 development	
in	 a	 tissue	 specific	 manner.	 Both	 clusters	 contain	 pseudogenes	 (y),	 which	 are	 remnants	 of	













hemoglobin	HbA	 (a2b2)	 starts	 replacing	 the	HbF	 a	 few	months	 before	birth,	 a	 process	which	
is	almost	completed	6	months	after	birth.	At	 this	time,	 the	bone	marrow	 is	 the	major	site	of	
hematopoiesis	 and	 hemoglobin	 synthesis.	 Another	 adult	 hemoglobin,	 HbA2,	 consists	 of	 two	





Figure 2 Overview	 of	 the	 a-	 (top	 panel)	
and	 b-globin	 gene	 cluster	 (bottom	 panel)	
and	 surrounding	 region.	 Locations	 along	
chromosomes	 16	 and	 11,	 respectively,	 are	
indicated	at	the	top	of	each	panel	 	and	are	
according	 to	 the	 UCSC	 Genome	 Browser	
2006	(hg18).	GC-percentage	differs	between	
the	globin	gene	clusters;	the	a-globin	gene	
cluster	 is	 GC-rich,	 whereas	 the	 b-globin	
gene	cluster	is	AT-rich.	The	area	surrounding	
the	 α-globin	 gene	 cluster	 contains	 many	
other	 genes	 with	 various	 functions.	 A	 few	
genes	 surround	 the	 b-globin	 gene	 cluster,	
they	 all	 belong	 to	 the	 family	 of	 olfactory	
receptor	 genes.	 Both	 clusters	 contain	
regulatory	 elements	which	 are	 responsible	
for	 correct	 expression	 of	 the	 globin	 genes.	
The	 a-globin	 gene	 cluster	 contains	 4	
multi-species	 conserved	 sequence	 regions	
(MCS-R	1-4).	The	locus	control	region	(LCR)	
of	 the	 b-globin	 gene	 cluster	 consists	 of	 5	
hypersensitive	 sites.	 The	 majority	 of	 the	
repetitive	 sequences	 in	 the	 a-globin	 gene	
cluster	 belongs	 to	 the	 Alu-family,	 while	
the	 b-globin	 cluster	 mainly	 contains	 LINE-




























Hemoglobinopathies and the public health problem
	 Hemoglobinopathies	are	hereditary	blood	disorders	caused	by	mutations	affecting	the	
globin	genes.	Mutations	may	cause	changes	in	the	globin	chain	structure	leading	to	abnormal	
hemoglobins	 (Hb	 variants),	 while	 mutations	 affecting	 the	 expression	 of	 the	 genes	 result	 in	
thalassemias	(a	or	b,	according	to	the	gene	affected).	The	hemoglobinopathies	represent	a	major	
public	health	problem	particularly	in	the	Mediterranean	area,	the	Middle	East,	India,	Southeast	





















	 Nowadays,	 national	 programs	 to	 identify	 carriers	 of	 hemoglobinopathy	 have	 been	
implemented	 in	many	 endemic	 countries	 to	 facilitate	 primary	 prevention,	which	 is	 based	 on	
information,	carrier	screening	and	counseling	(11-16).	Carrier	screening	can	take	place	at	several	
stages,	 including	 the	 premarital	 or	 preconceptional	 phase,	 during	 early	 pregnancy	 and	 after	
newborn	 screening	 (17-19).	 Couples	 at	 risk	 can	 be	 offered	 an	 informed	 reproductive	 choice,	
including	termination	of	an	affected	pregnancy	after	prenatal	diagnosis.	Since	2007,	sickle	cell	
disease	 has	 been	 included	 in	 the	 national	 newborn	 screening	 program	 in	 the	 Netherlands.	
However,	a	better	preventative	strategy	is	urgently	needed	to	detect	carriers	before	pregnancy	
or	at	the	first	pregnancy	visit,	as	is	commonly	done	in	other	countries	(20).	Therefore,	a	study	
has	 been	 performed	 to	 examine	 the	 feasibility	 of	 standardized	 hemoglobinopathy	 carrier	
testing	 for	 pregnant	 women	 in	 the	 Netherlands.	 This	 study	 showed	 that	 the	 prevalence	 of	
hemoglobinopathy	carriers	 is	high	enough	 in	 the	Dutch	population	 to	warrant	 testing	 for	 the	
entire	 multiethnic	 population	 during	 early	 pregnancy.	 Such	 an	 intervention	 could	 be	 easily	
performed	at	the	national	level	when	included	in	the	ongoing	early	pregnancy	screening	(PSIE)	
for	Rhesus	antagonism	and	infectious	diseases	(21;22).	
Figure 5	 Global	 incidence	 of	 hemoglobin	 disorders	 (adapted	 from	 the	World	Health	Organization,	
http://www.who.int)
17














	 Until	 now,	more	 than	 1100	hemoglobin	 variants	 have	 been	 described	 and	 reported	
in	HbVar,	which	 is	a	 locus	specific	database	developed	 in	2001	to	provide	 information	on	the	
genomic	sequence	changes	leading	to	Hb	variants,	thalassemias	and	hemoglobinopathies	(23-
25).	Most	 Hb	 variants,	 unless	 associated	with	molecular	 instability,	 are	 recessive	 and	 only	 a	
relatively	small	number	of	these	abnormal	hemoglobins	can	cause	severe	diseases	in	homozygous	
or	compound	heterozygous	combinations.	The	most	frequently	occurring	mutation	is	associated	

























Figure 7	 Vaso-occlusion	 of	 the	
microcirculation.	 When	 oxygen	
tension	 drops,	 erythrocytes	
containing	 hemoglobin	 S	 will	




veins	 and	 oxygen	 deprivation	 of	
the	 downstream	 tissue	 (Adapted	
from	Healthwise	Inc.).
Beta-thalassemia
	 In	b-thalassemia,	 the	 expression	 of	 the	b-gene	 on	 one	 or	 both	 alleles	 is	 absent	 or	






	 Thalassemia	 intermedia	 (TI)	 arises	when	 the	expression	of	both	b-genes	 is	 reduced,	
but	one	or	both	of	 the	mutations	 is	 relatively	mild	so	that	a	significant	amount	of	b-globin	 is	







and	 by	 6	 months	 of	 life	 symptoms	 of	 severe	 anemia	 become	 apparent.	 The	 bone	 marrow	
becomes	hyperactive	to	compensate	for	severe	hemolytic	anemia.	However,	the	majority	of	the	








only	possibility	 of	 cure	 is	 a	 successful	 hematopoietic	 stem	cell	 transplantation	 in	 young	non-
compromised	patients	with	an	HLA	matching	donor	(31-33).
Genetic modifiers of beta-thalassemia
	 Although	 the	 phenotypes	 of	 thalassemia	 minor,	 intermedia	 and	 major	 are	 classic,	
the	 clinical	manifestations	 of	b-thalassemia	 can	 also	 be	 extremely	 diverse,	 ranging	 from	 the	











	 Furthermore,	an	 inherent	capacity	 to	produce	g-globin	chains,	which	 form	HbF	with	
the	 excess	 of	a-globin	 chains,	may	 also	 reduce	 the	 globin	 chain	 imbalance	 in	b-thalassemia.	





itself.	Mutations	or	deletions	 in	 the	promoter	 region,	or	 larger	deletions	 involving	 the	d-	and
20
b-globin	 genes,	 inhibit	 interaction	 of	 the	 b-globin	 gene	 with	 the	 locus	 control	 region	 (LCR,	
described	below).	These	deletions	are	associated	with	the	removal	of	silencer	elements	in	the	
region	between	g-	 and	d-globin	genes	or	 the	 removal	of	enhancer	elements	 in	 the	proximity	
of	the	g-globin	genes	(42;43).	This	eliminates	the	competition	between	the	g-globin	genes	and	





trans-acting	 factors	 influencing	 the	 g-globin	 gene	 expression.	 Loci	 linked	 to	 increased	 HbF	
production	 include	 the	HBS1L-MYB	 intergenic	 region	on	 chromosome	6q23	 (45),	 the	BCL11A	
gene	on	chromosome	2p15	 (46;47)	and	 the	KLF1	gene	on	chromosome	19p	 (48).	HBS1L	and	
MYB	 play	 a	 role	 in	 hematopoiesis,	 and	 it	 has	 been	 shown	 that	 this	 region	 contains	multiple	










more	 tilted,	 causing	 b-thalassemia	 intermedia	 phenotypes	 in	 b-thalassemia	 heterozygous	
patients.	These	patients	present	with	more	severe	symptoms	and	may	be	transfusion	dependent	
at	regular	 intervals.	The	severity	of	 this	condition	 is	determined	by	the	type	of	b-globin	gene	
mutation	 (b+	or	b0)	and	 the	number	of	 functional	a-globin	genes.	A	 triplicated	a-globin	gene	
on	one	allele	 (aaa/aa)	 in	combination	with	a	b+-thalassemia	 leads	 to	a	slightly	more	severe	
phenotype	 (54).	On	 the	 other	 extreme,	 a	 combination	 of	 a	 triplicated	a-globin	 gene	 on	 one	
allele,	a	duplication	of	the	whole	a-globin	gene	cluster	on	the	other	allele	(aaa/aaaa)	and	a	
b0-thalassemia	results	in	a	severe	phenotype	and	transfusion	dependency	(55).
Hereditary persistence of fetal hemoglobin (HPFH)
	 Hereditary	 persistence	 of	 fetal	 hemoglobin	 (HPFH)	 is	 a	 phenotypic	 condition	
characterized	by	an	abnormal	high	presence	of	fetal	hemoglobin	during	adulthood.	The	precise	
molecular	mechanism	 causing	 HPFH	 is	 still	 unclear.	 However,	 in	many	 cases	 the	 condition	 is	















	 Non-deletional	 HPFH	 is	 a	 benign	 condition	while	 deletional	 defects	may	 result	 into	
thalassemia	intermedia	when	combined	with	b0-thalassemia	defects.	Carriers	will	often	remain	
unaware	 of	 their	 condition	 because	 of	 their	 normal	 Hb	 levels.	 A	 conscious	 GP	might	 decide	
to	 investigate	 their	 erythrocytosis,	 caused	 by	 the	 higher	O2	 affinity	 of	 fetal	 hemoglobin,	 and	
consequent	mild	chronic	hypoxia	(58;59).
The egdb- and gdb-thalassemias










	 At	 the	 molecular	 level	 the	 (egdb)0-thalassemias	 can	 be	 roughly	 divided	 into	 two	
categories.	 The	first	 group	 includes	 large	deletions,	which	have	 removed	all	 genes	 located	 in	
the	b-globin	gene	cluster;	the	second	group	has	been	found	in	association	with	intact	b-globin	
genes.	These	deletions	silence	b-globin	gene	expression	and	led	to	the	discovery	of	the	upstream	
regulatory	 element	 or	 locus	 control	 region	 (bLCR).	 Several	 deletions	 of	 this	 kind	 have	 been	











Figure 8 Deletions	 in	 the	b-globin	 gene	 cluster. (a)	 Large	deletions	extending	beyond	 the	b-globin	
gene.	The	extent	of	each	deletion	 is	 represented	by	a	black	bar.	The	thin	bars	at	both	ends	of	 the	
thick	bar	denote	the	regions	of	uncertainty	for	the	deletion	breakpoints.	(b)	Deletions	restricted	to	
the	b-globin	gene.	 (Adapted	from	‘Disorders	of	hemoglobin,	Genetics,	pathophysiology	and	clinical	






a-globin	production,	 extending	 from	none	 at	 all	 to	 very	near	normal	 levels.	 The	 latter	 is	 the	




































a	 massively	 enlarged	 placenta.	 Common	 maternal	 complications,	 which	 usually	 arise	 in	 the	
third	trimester	of	pregnancy,	include	anemia,	hypertension,	polyhydramnios,	oligohydramnios,	
hemorrhage	 and	 the	 premature	 onset	 of	 labor.	 Complications	 after	 delivery	 include	 retained	










Alpha-thalassemia and mental retardation
	 Two	types	of	a-thalassemia	are	known	to	be	associated	with	mental	retardation,	the	
ATR-X	and	ATR-16	syndromes.	The	ATR-X	syndrome	arises	due	to	a	mutation	 in	the	XH2	gene,	
located	 on	 the	 X-chromosome.	 This	 gene	 encodes	 X-linked	 helicase-2,	 which	 is	 a	 putative	













in	 carriers	 (68;70).	 The	 phenotype	 is	 determined	 by	 the	 extent	 of	 haplo-insufficiency	 of	 the	









factor	 gene	 SOX-8)	 is	 located	 in	 this	 region	 and	 is	 involved	 in	 the	 regulation	 of	 embryonic	
development	and	 in	 stem	cell	differentiation	 in	mice	 (75).	The	encoded	protein	may	act	as	a	
transcriptional	activator	after	forming	a	protein	complex	with	other	proteins.	This	protein	may	















and	 this	 condition	 is,	 therefore,	 referred	 to	 as	 ‘alpha-thalassemia	myelodysplastic	 syndrome’	
(ATMDS)	 (86).	 However,	 acquired	a-thalassemia	 is	 not	 unique	 to	MDS,	 it	 is	 also	 reported	 to	
be	 associated	 with	 acute	 lymphoblastic	 leukemia	 (ALL),	 acute	 myeloid	 leukemia	 (AML)	 and	
myelofibrosis	(87;88).
	 An	acquired	deletion	of	 the	 telomeric	 region	of	 chromosome	16p	was	 found	 in	one	
ATMDS	patient	with	a	complex	karyotype.	This	deletion	was	limited	to	the	neoplastic	clone	and	




at	 chromosome	 Xq13.3	 (90;91).	 Because	 inherited	 and	 acquired	 mutations	 in	 ATRX	 cause	
a-thalassemia,	it	is	suggested	that	this	gene	plays	a	role	in	a-globin	gene	expression.	However,	






Figure 9	 Deletions	 in	 the	 a-globin	 gene	 cluster.	 (a)	 Rare,	 large	 deletions	 extending	 beyond	 the	
a-globin	 gene	 cluster	 that	 cause	a-thalassemia	 but	 no	 other	 associated	 anomalies.	 The	 extent	 of	






















	 The	 b-globin	 LCR	 is	 located	 6-20	 kb	 upstream	 of	 the	 b-gene.	 It	 consists	 of	 five	




studies	 indicate	 that	 the	HS-40,	 or	MCS-R2,	 is	 the	most	 conserved	 element	 and	 is	 therefore	
considered	 as	 the	major	 regulatory	 element.	 In	 addition,	 the	HS-33,	 -10	 and	 -8	 cannot	 drive	
substantial	 levels	 of	a-globin	 expression	 on	 their	 own	 (96-99).	 However,	 a	 patient	 with	 two	







B. Postnatal diagnosis of hemoglobinopathies






































gene	 cluster	 involving	 one	 (a+)	 or	 both	 (a0)	a-globin	 genes.	 The	 gap-PCR	method	 is	 used	 to	
detect	the	seven	most	common	a-thalassemia	causing	deletions	(-a3.7,	-a4.2,	--SEA,	--MedI,	-(a)20.5,	









method,	 little	 input	DNA	 is	 needed	 and	 no	 radioactivity	 is	 used	 (106).	Necessary	 equipment	
includes	a	thermal	cycler	and	an	agarose	gel	electrophoresis	facility,	which	are	available	in	most	
molecular	laboratories	in	countries	where	hemoglobinopathies	frequently	occur.	Although	this	
method	 is	 suitable	 to	 detect	 the	 majority	 of	 the	 deletional	a-thalassemias,	 uncharacterized	

















to	generate	smaller	 fragments	which	are	suitable	 to	use	 for	direct	sequencing.	This	approach	





Multiplex Ligation-dependent Probe Amplification
	 Traditional	methods	to	detect	CNVs	with	uncharacterized	breakpoints	include	techniques	
such	as	Southern	blotting	and	fluorescent	in-situ	hybridization	(FISH)	(107).	However,	Southern	
blot	 analysis	 is	 time	 consuming,	 technically	 demanding	 and	 success	 is	 very	much	dependent	



























	 However,	 generating	 these	 cloned	 cosmid	 probes	 is	 laborious,	 time-consuming	 and	












remained	 unsolved	 after	 applying	 the	 standard	 diagnostic	methods.	 This	 study	 showed	 that	
MLPA	is	a	helpful	method	in	routine	diagnostics,	especially	in	populations	in	which	a	large	variety	
of	 deletion	 mutations	 occur.	 Furthermore,	 several	 rearrangements	 that	 were	 not	 described	
previously	were	detected	during	this	study.
31




because	 the	distance	between	 the	MLPA	probes	 varies	 from	a	 few	hundred	base	pairs	up	 to	
>10	kb.	Although	not	essential	for	demonstrating	the	presence	of	a	deletion	defect,	knowledge	
of	the	exact	breakpoint	is	important	from	a	scientific	point	of	view	to	unravel	the	mechanisms	




	 The	 standard	 method	 to	 characterize	 such	 rearrangements	 is	 to	 randomly	 design	
primers	in	the	breakpoint	region	and	perform	PCR	across	the	breakpoint.	The	breakpoint	region	
is	determined	by	the	most	proximal	and	most	distal	MLPA	probe	still	present	and	the	first	probe	
involved	 in	 the	 deletion.	 The	 distance	 between	MLPA	 probes	 generally	 range	 between	 3-10	














causing	 neuroblastoma	 at	 sub-kilobase	 resolution	 on	 four	 different	 chromosomes	 (126).	 The	























Figure 11 Outline	of	 the	array	CGH	technique.	Test	DNA	and	reference	DNA	samples	are	prepared	
separately.	One	sample	is	labeled	with	cyanine-5	fluorescent	dye	(red),	and	the	other	with	cyanine-3	
(green).	Samples	are	then	mixed	and	hybridized	onto	the	array	slide.	By	scanning	the	slide	after	~72	












as	 part	 of	 a	 national	 primary	prevention	program	by	 applying	different	 techniques,	 including	





























During	 the	procedure,	a	 small	 volume	of	amniotic	fluid,	 containing	 fetal	 cells,	 is	extracted	by	

















	 The	 discovery	 of	 free	 fetal	 DNA	 (ffDNA)	 circulating	 in	 the	 maternal	 blood	 during	
pregnancy	 has	 lead	 to	 the	 possibility	 to	 perform	 non-invasive	 prenatal	 diagnosis	 (NIPD)	 for	













mutations	 or	 polymorphisms	 inherited	 from	 father.	 The	 PAP	 technique	 has	 already	 been	
successfully	applied	for	fetal	sex	determination	(147).	








number	of	 assays	 to	be	designed	 can	be	 limited	 to	<20	polymorphisms,	 instead	of	designing	
assays	 for	 the	 >200	 described	 b-thalassemia	 mutations.	 The	 melting	 curve	 analysis	 (MCA)	
technique	can	be	used	to	screen	family	members	for	informative	SNPs	and	to	determine	linkage	
to	 the	 normal	 or	 mutant	 allele.	 MCA	 is	 an	 assessment	 of	 the	 dissociation-characteristics	 of
36
double-stranded	DNA	during	heating.	A	fluorescent	dye	is	incorporated	during	the	PCR,	of	which	





12).	Chapter 3.2	describes	 the	application	of	 the	PAP-technique,	 in	combination	with	melting	
curve	analysis	(MCA),	for	non-invasive	prenatal	diagnosis	of	b-thalassemia	and	sickle	cell	disease.	







Aim of this thesis
	 The	main	objective	of	this	thesis	was	to	improve	post-	and	prenatal	diagnostics	of	the	
hemoglobinopathies.	 Several	molecular	 assays	 have	been	designed,	 tested	 and	 validated.	 	 In	
addition,	a	number	of	informative	hemoglobinopathy	cases	have	been	studied	in	detail.	Chapter 
2.1	describes	the	development	of	a	single-tube	multiplex	gap-PCR	for	rapid	detection	of	eight	
different	 deletions	 in	 the	b-globin	 gene	 cluster.	 The	 design	 of	 an	MLPA-based	 technique	 for	






in	the	globin	gene	clusters	 in	couples	at	risk.	Prenatal	diagnosis	might	 lead	to	a	 false	adverse	
result,	when	 the	 fetus	 has	 inherited	 a	 point	mutation	 from	one	 parent	 and	 a	 deletion	 allele	




Chapter 3.2. Chapter 4	 is	comprised	of	 two	case	studies	on	 the	molecular	characterization	of	
novel	deletions	in	the	a-globin	gene	cluster.	These	studies	stress	the	importance	of	MLPA	as	a	
diagnostic	screening	tool	and	the	use	of	aCGH	to	obtain	additional	information	about	the	exact	
breakpoints	 to	be	able	 to	design	a	gap-PCR	assay.	 It	 is	 important	 to	be	able	 to	diagnose	 this	
kind	of	deletions;	because	of	a	25%	risk	of	Hb	Bart’s	with	hydrops	fetalis	in	the	offspring	when	




SNPs.	First,	 the	SNPs	are	genotyped	by	MCA	 in	 father,	mother	and	first-born	child	 (or	other	 family	
member)	 and	 linkage	 to	 the	mutant	 paternal	 allele	 is	 determined.	 PAP	 is	 used	 to	 detect	 paternal	
SNPs	in	ffDNA	isolated	from	maternal	plasma.	In	this	way,	it	can	be	determined	which	paternal	allele	
is	 inherited	by	 the	 fetus.	 In	case	 the	mutant	allele	 is	detected,	an	 invasive	prenatal	diagnosis	 (PD)	

















(6)		 Aguileta	 G,	 Bielawski	 JP,	 Yang	 Z.	 Evolutionary	 rate	 variation	 among	 vertebrate	 beta	 globin 

























































































































































































































































































































































A single-tube multiplex gap-PCR for the detection of eight 
b-globin gene cluster deletions common in Southeast Asia
Tritipsombut J, Phylipsen M, Viprakasit V, Chalaow N, Sanchaisuriya K, 





	 Up	 to	 now,	 more	 than	 200	 different	 b-thalassemia	 (b-thal)	 mutations	 have	 been	
characterized.	The	majority	are	point	mutations	causing	expression	defects.	Only	approximately	
10.0%	of	the	defects	are	caused	by	large	deletions	involving	the	b-globin	gene	cluster	causing	








thal,	 the	 Siriraj	 I	 Gg(Agdb)0-thal,	 the	Chinese	 Gg(Agdb)0-thal,	 the	Asian	 Indian	deletion-inversion	
Gg(Agdb)0-thal	 as	well	 as	 the	 (hereditary	persistence	of	 fetal	hemoglobin)	HPFH-6	and	HPFH-7	
deletions.






 b-Thalassemia	 (b-thal)	 is	 a	 group	 of	 disorders	 resulting	 from	 a	 reduced	 or	 absent	
synthesis	of	b-globin	 chains	 [1].	 In	human,	 the	b-globin	gene	cluster	 is	 approximately	50,000	














	 Up	 to	 the	 present	 time,	 more	 than	 200	 different	 b-thal	 [4]	 mutations	 have	 been	
characterized.	Most	of	them	result	 from	point	mutations	causing	a	reduced	expression	of	the	
b-globin	gene	[5].	Alternatively,	deletions	may	involve	the	b-globin	gene	or	regulatory	elements,	














	 A	 number	 of	 polymerase	 chain	 reaction	 (PCR)-based	 techniques	 such	 as	 restriction	
endonuclease	 (RE),	 Southern	 blotting	 and	 multiplex	 ligation-dependent	 probe	 amplification	
(MLPA)	 have	 been	 applied	 for	 characterization	 of	 rare	 and	 unknown	 b-globin	 gene	 cluster	
deletions.	 However,	 the	most	 widely	 technique	 used	 is	 gap-PCR	 that	 uses	 only	 two	 specific	
primers	 complementary	 to	 the	 sense	 and	 antisense	 strand	 in	 the	 DNA	 regions	 flanking	 the	






	 To	 improve	 rapid	 diagnostics	 for	 detection	 of	 eight	 b-globin	 cluster	 deletions	 in	
Southeast	Asian	countries,	a	simple	molecular	technique	based	on	a	single-tube	multiplex	gap-








































































HPFH HPFH-6	[23] 54,361 124,872d Thailand
HPFH-7	[24] 33,468 4,799 Vietnam
Table 1	Deletion	breakpoints	of	b-globin	gene	cluster	found	in	Southeast	Asian	countries	[4-24].	
aData	 from	 HbVar	 ID	 989	 (HGVS	 name	 NG_000007.3),	 bData	 from	 HbVar	 ID	 1046	 (HGVS	 name	
NG_000007.3),	 cCharacterized	 by	MLPA	 and	 direct	 sequence	 analysis,	 dData	 from	 HbVar	 ID	 1048	
(HGVS	name	NG_000007.3).
Southern	blotting	or	 direct	 sequence	 analysis	 of	 breakpoint	 fragments	were	used	 as	 positive	
controls	 for	optimizing	 the	conditions	of	multiplex	gap-PCR.	 In	first	 instance,	due	to	a	 limited	
availability	of	DNA	of	patients	 to	be	used	as	positive	control	 for	 the	detection	of	 the	Siriraj	 I	


























temperature	 (Tm)	of	 the	 Lepore	primer	pair	 as	 shown	 in	 Table	 2.	 The	double-step	 annealing	
multiplex	PCR	has	been	shown	to	work	well	with	the	high	Tm	primers	[29].	
  


























































































































Table 2	 Primer	details	 in	 a	 single-tube	multiplex	 gap-PCR	 for	 detection	of	 the	 eight	b-globin	 gene	
cluster	deletions	in	Southeast	Asian	countries	(Tm	is	the	melting	temperature	of	each	primer)
	 Several	types	of	Hb	Lepore	have	been	described	based	on	their	deletion	breakpoints.	
They	 include	 Hb	 Lepore-Hollandia	 (d22Ala/b50Thr),	 Hb	 Lepore-Baltimore	 (d50Ser/b86Ala	

























	 In	 conclusion,	 a	 simple	 molecular	 technique	 based	 on	 a	 single-tube	multiplex	 gap-




which	 is	available	 in	most	clinical	molecular	 laboratories	screening	for	hemoglobinopathies	 in	
Asia	where	the	incidence	of	b-thal	is	high.	
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Nine unknown rearrangements in 16p13.3 and 11p15.4 
causing alpha- and beta-thalassaemia characterised 
by high resolution multiplex ligation-dependent probe 
amplification
Harteveld CL, Voskamp A, Phylipsen M, Akkermans N, den Dunnen JT, 







11p15.5	 respectively.	 Gap-PCR,	 Southern	 blot	 analysis,	 and	 fluorescent	 in	 situ	 hybridisation	
are	commonly	used	to	identify	these	deletions;	however,	many	deletions	go	undetected	using	
conventional	techniques.	
	 Methods:	 Patient	 samples	 for	 which	 no	 abnormalities	 had	 been	 found	 using	















	 Thalassaemias	 are	 inherited	 haemoglobin	 disorders	 characterised	 by	 a	 quantitative	




Besides	 the	 most	 common	 ones	 a	 large	 variety	 of	 less	 frequently	 occurring	 thalassaemia	
















deletions	and	duplications	are	common	 [12-14].	 	 In	 the	original	description,	 the	probes	were	
generated	by	 cloning	 into	 specially	developed	M13	vectors.	Recently,	we	have	 simplified	 this	
method	by	using	chemically	synthesised	oligonucleotides.	 	Discrimination	of	probes	based	on	
chemically	 synthesized	 oligonucleotides	 (~40-60	 nt)	 was	 doubled	 using	 two	 universal	 primer	
sets	each	labelled	with	a	different	fluorophore,	allowing	up	to	40	probes	to	be	used	in	a	single	
reaction	[15].	
	 To	 simplify	 the	 detection	 of	 a-	 and	 b-thalassaemia	 deletions	 and	 increase	 the	
resolutions,	we	designed	two	probe	sets	for	each	cluster.	For	the	a-cluster,	two	probe	sets	of	
35	probe	pairs	in	total	were	designed	with	an	average	distance	of	~20	kb,	covering	a	genomic	
















one	 mutation,	 suggesting	 a	 deleted	 allele	 in trans.	 Some	 showed	 the	 presence	 of	 possible	
junction	fragments	by	Southern	blot,	 in	which	the	deletion	could	not	be	characterised	due	to	
lack	of	probes	in		the	region	flanking	the	potential	deletion.	In	total,	38	possible	a-thalassaemia	
carriers	 were	 selected	 to	 be	 screened	 for	 rearrangements	 in	 16p13.3.	 These	 samples	 were	
collected	during	a	period	of	approximately	5	years.	
	 Patients	were	selected	who	presented	with	a	microcytic	hypochromic	anaemia	in	the	
presence	of	elevated	HbA2	 levels,	 for	which	standard	DNA	analysis	 revealed	no	abnormalities	
in	the	b-globin	gene	sequence	or	the	5’and	3’UTR.	These	samples	 include	patients	showing	a	
high	HbF	expression,	indicative	for	HPFH,	(db)0-	or	Gg(Agdb)0-thalassaemia,	and	patients	showing	
normal	 HbA2	 and	 HbF	 levels	 with	 a/b	 chain	 synthesis	 ratios	 higher	 than	 1.5,	 indicative	 for	
deletions	involving	the	complete	cluster	and/or	the	regulatory	elements.	A	total	of	51	samples	
were	analysed	by	MLPA.		
	 As	positive	controls	 for	MLPA	of	 the	a-globin	gene	cluster,	we	used	seven	deletions	
confirmed	previously	by	gap-PCR	(-	-	SEA,	-a3.7	,	-a4.2,	-	-	Med	I,	-	-	FIL,	-	-	THAI	and	–	(a)20.5	,	indicated	
as	black	bars	 in	Figure	1B).	Two	other	deletions	(33	kb	-	 -Dutch	I	and	the	-a7.	9)	 	were	previously	




kb	 Dutch	 I	 b0-thalassaemia	 [24]	 and	 the	 Indian	 (-619	 bp)	 b0-thalassaemia	 deletions	 [25],	 all	
previously	characterised	by	Southern	blot	analysis,	were	used	as	positive	controls	(Figure	2).
Probe design
	 In	 total	 35	 probe	 pairs	 were	 designed	 to	 detect	 rearrangements	 on	 16p13.3,	
covering	 approximately	 700	 kb	 from	 the	 telomere	 to	 the	MSLN	 gene	 (Table	 3,	 Figure	 1).	 For	
each	 probe	 pair,	 the	 common	 ends	 correspond	 to	 either	 the	 MLPA	 amplification	 primers	
(forward	 tag	 5’-GGGTTCCCTAAGGGTTGGA-3’;	 reverse	 tag	 5’-TCTAGATTGGATCTTGCTGGC-3’)	
[11]	 or	 the	 multiplex	 amplifiable	 probe	 hybridisation	 (MAPH)	 primers	 (forward	 tag	
5’-GGCCGCGGGAATTCGATT-3’;	 reverse	 tag	 5’-CACTAGTGAATTCGCGGC-3’)	 [26],	 which	 allows	
simultaneous	amplification	and	detection	of	the	separated	fragments	in	different	colours.		










sequencer	 (Applied	Biosystems,	Foster	City,	CA).	Primers	have	been	designed	using	 the	 	RAW	
program	(MRC-Holland,	Amsterdam,	The	Netherlands)	such	that	the	melting	temperature	of	the	
hybridising	regions	of	each	probe	was	at	least	65oC	with	a	GC	percentage	between	35%	and	60%.	














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































intervals	of	13-50	kb	with	the	most	proximal	probe	 localised	 in	 the	MSLN	gene,	known	to	be	
deleted	in	the	alpha-thalassaemia	mental	retardation	syndrome	(ATR-16)	[28,29].	The	35	probe	
pairs	shown	in	Table	3	can	detect	all	of		the	deletions	described	to	date.	






and	heterozygote	 carrier	 for	 the	 common	 	 -a3.7	 deletion,	which	 results	 in	 the	 loss	 of	 the	a2-
specific	3’UTR	and	a	heterozygote	 for	 the	so	called	a-triplication,	which	 is	 characterised	by	a	
duplication	of	the	a2-specific	3’UTR.	The	results	are	summarised	in	Figure	3.	
73
MLPA for b-thalassaemia rearrangements and HPFH
	 Similar	to	the	a-cluster,	34	probes	were	designed	for	loci	in	the	b-globin	gene	cluster	











deleted	 loci	 showed	half	 the	 intensity	of	 the	surrounding	probes,	matching	the	positions	and	
extensions	of	all	the	six	known	deletions.	




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































length	 estimations	 were	 obtained	 by	 MLPA,	 being	 	 between	 128-143	 kb	 and	 109-122	 kb,	
respectively.	The	other	three	showed	similarity	to	the	Dutch	I	12.6	kb	b0-thalassaemia	deletion	
(in	seven	independent	patients	of	Dutch	origin),	the	13.4	kb	Sicilian	(db)0-thalassaemia	deletion,	



































	 In	 19	 and	 20	 samples	 large	 rearrangements	 involving	 the	 a-	 and	 b-globin	 genes,	













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	 Polymorphisms	 in	 the	 genome,	 interfering	with	 probe	 annealing	 and	 ligation	of	 the	
two	 probe	 pairs,	may	 cause	 the	 loss	 of	 probe	 signal	 leading	 to	 a	 false	 positive	MLPA	 result	








this	deletion,	which	 is	at	maximum	30	kb	 in	 length,	 involves	also	HS-33	as	 found	by	Higgs	et	
al.	 [38]	needs	 further	analysis.	 These	 types	of	deletions	 in	human	carriers	may	 contribute	 to	
understand	the	mechanisms	involved	in	regulation	of	downstream	a-gene	expression	[39]	and	
will	be	studied	further.	
	 In	 conclusion,	MLPA	 is	 an	 attractive	 alternative	 for	 FISH	 analysis	 for	 screening	 large	
deletions,	 for	example	 in	ATR-16	syndrome	[9,10].	The	tiling	paths	of	cloned	probes	currently	
available	 for	 cytogenetic	 analysis	 of	 the	 16p13.3	 and	 11p15.4	 are	 shown	 in	 Figure	 1	 and	 2.	





electrophoresis.	 Since	 most	 diagnostic	 laboratories	 have	 these	 technologies	 operational,	
implementation	 of	MLPA	 should	 be	 straightforward.	 The	 robustness,	 simplicity,	 and	 intrinsic	
redundancy	(probe	density)	of	this	approach,	and	the	additional	specificity	offered	by	the	ligation	
step,	make	MLPA	an	attractive	technique	for	the	detection	and	characterisation	of	copy	number	











three	windows,	 the	peaks	are	 split	 by	 colour.	Within	each	probe	 set,	 two	probes	 for	unlinked	 loci	
were	 included	as	a	reference	(marked	by	an	asterisk).	At	the	right	are	scatter	plots	are	shown	of	a	
wildtype	and	a	heterozygote	for	the	Dutch	IV	(eg)db0-thalassaemia	deletion.	The	corresponding	probes	
in	different	 colours	are	ordered	according	 to	 their	position	along	 the	b-globin	gene	cluster	on	 the	
x-axis,	the	y-axis	showing	the	ratios	calculated	for	each	probe.	 	(B)	The	first	scatter	plot	represents	
the	deletion	of	all	the	a-cluster	specific	probes	on	one	allele	as	found	in		the	-	-	GZ a0-thalassaemia	
deletion;	the	two	 independent	control	probes	are	 indicated	on	the	right.	 	The	second	 	scatter	plot	
















































































































Thalassemia in Western Australia: 11 novel deletions 
characterized by Multiplex Ligation-dependent Probe 
Amplification
Phylipsen M, Prior JF, Lim E, Lingam N, Vogelaar IP, Giordano PC, 





	 The	 number	 of	 immigrants	 in	 Western-Australia	 from	 many	 different	 areas	 where	
hemoglobinopathies	are	endemic	has	increased	dramatically	since	the	1970s.	Therefore,	many	
different	thalassemia	mutations	have	been	introduced	in	the	country,	which	add	a	technological	
diagnostic	 problem	 to	 the	 serious	 burden	 of	 hemoglobinopathy	 management	 and	 to	 public	
health	care.
	 Recently,	 we	 have	 developed	 a	 rapid	 and	 simple	 technique	 based	 on	 Multiplex	
Ligation-dependent	 Probe	 Amplification	 to	 detect	 deletions	 causing	 a-	 and	 b-thalassemia,	
db-thalassemia	 and	 Hereditary	 Persistence	 of	 Fetal	 Hemoglobin.	 A	 screening	 for	 (unknown)	
deletions	was	performed	in	a	cohort	of	patients	of	different	ethnic	backgrounds	preselected	for	
their	thalassemia	phenotype,	in	which	common	deletions	and	point	mutations	were	excluded.

















the	 globin	 gene	 clusters	 have	 been	 described	 (http://globin.cse.psu.edu/hbvar/menu.html).	
	 The	present	Western	Australian	population	consists	for	more	than	30%	of	immigrants,	
mainly	of	northwest	European	extraction.	However,	 since	 the	1970s	an	 increasing	number	of	
immigrants	are	from	Southeast	Asia	and	Sub-Saharan	Africa,	where	hemoglobin	disorders	are	
prevalent.	Many	thalassemia	mutations	have	been	introduced	due	to	this	migration	profile	and	












Amplification	 (MLPA)[10]	 to	 perform	 high	 resolution	 screening	 for	 unknown	 rearrangements	
on	 chromosome	 11p15.4	 and	 on	 the	 telomeric	 region	 of	 chromosome	 16p,	 causing	 b-	 and	
a-thalassemia,	respectively	[11].	We	have	introduced	the	MLPA	assay	in	our	standard	diagnostic	
protocol	 to	 be	 used	 for	 those	 thalassemic	 cases	 that	 remain	 uncharacterized	 after	 sequence	
analysis	and	gap-PCR	for	the	common	deletions.	
	 In	the	current	study,	we	screened	a	hematological	well-diagnosed	subset	of	thalassemia	















	 The	MLPA	reactions	were	performed	according	 to	a	protocol	based	on	 the	methods	
described	before	[10,	12],	and	conditions	were	adjusted	for	detection	of	copy	number	variation	
in	the	a-	and	b-globin	gene	clusters	[11].	Products	were	separated	by	capillary	electrophoresis	




















Ferritin IB Delet ion	
of	probe	#
Mutation Fig.1
1 Chinese F 52 12,1 68 22 5,2 0,5 	282 - None None
2 Caucasian M 37 14,8 74 25 5,4 0,5 	274 - None None
3 unknown F 52 12 77 26 5,9 0,4 	17 ND	 None None
4 Sudan	 F 6 11 74 26 2,5 9,6 	47 ND	 dup.	16b
5 Asian F 44 14 71 22 2,7 	0.7 40 - None None
6 Italian F 48 12,4 71 22 2,2 <1.0 88 - None None
7 unknown F 17 11,1 72 22 2,6 <1.0 47 - None HBA2:c.301-24delGins	
CTCGGCCC
8 unknown F 8 7,6 62 19 2,7 <1.0 101 - None None
9 Spanish F 19 11,5 68 22 2,5 	0.4 50 - None None
10 unknown F 17 11,6 67 21 2,3 <1.0 20 - 10a-15a A*
11 Arab F 23 11,9 66 21 2,6 	0.2 31 - 10a-15a A*
12 Indonesian F 16 12,9 65 20 2,5 <0.5 36 + 10a-15a A*
13 Indian M 46 12,3 66 21 2,5 	0.3 100 - 10a-16a B
14 unknown M 8 11,7 63 20 2,5 <1.0 30 + 10a-16a B
15 unknown M 46 14,7 66 21 2,6 <0.5 106 + 8a-16a C
16 unknown M 45 13,2 69 22 2,6 <0.2 119 - 8a-18a D
17 Caucasian M 46 14 73 24 2,7 	0.5 139 - 5a E*
18 Chinese M 24 13,3 69 23 2,9 	7.4 114 - 5a E*
19 Mediterranean	 F 36 12,9 66 21 2,5 <1.0 31 - 1a-20a F
20 Arab F 3 12,3 69 23 2,7 	0.9 55 - 25b G
21 African F 15 14,3 65 21 6,9 7 	54 ND	 23b-24b H
22 Sierra	Leone	 F 28 10,6 64 21 7,3 8,2 	70 ND	 23b-24b H
23 unknown F 40 11,3 70 22 7,2 5,9 	53 ND	 23b-25b K
24 Chinese F 29 11,8 70 22 3,6 19,5 	87  - 22b-26b L
25 Chinese M 58 13,1 78 25 4,4 19,5 	441 - 22b-26b L
26 Chinese M 58 13 75 24 5,4 14,7  112 - 22b-26b L
27 Mediterranean	 M 73 9,7 69 22 2,8 8,5 	97 - 20b-25b	 13.4	kb	Sicilian M
28 unknown M 23 14,3 67 22 2,8 11,2 	88 - 20b-25b 13.4	kb	Sicilian M
29 Italian F 57 11,5 72 23 2,6 11,1 	ND - 20b-25b 13.4	kb	Sicilian M
30 Italian F 29 11,5 63 20 2,9 9,6 	78 - 20b-25b 13.4	kb	Sicilian M
31 Italian M 46 12.9 65 21 4.9 0.7 	105 - 20b-25b M
32 Caucasian M 23 13,5 59 19 3 	1.8 82 - 16b-25b N
33 Thai ? 38 12,1 74 25 1,9 21,6  12 - 16-b29b O
34 unknown M 71 14,3 73 24 2,4 9,5 	70 - 17b-26b P
35 Mediterranean	 F 42 11,1 68 21 2,4 11,4 	13 - 17b-26b P
36 Chinese F 43 13,8 75 23 2,6 12 	231 ND	 17b-29b Q











	 In	 most	 diagnostic	 laboratories,	 a	 subset	 of	 thalassemia	 phenotypes	 in	 which	 no	
molecular	 defect	 has	 been	 found	 by	 the	 common	 techniques	 remains	 uncharacterized.	
However,	these	cases	remain	suspected	of	a	possible	thalassemia	based	on	persisting	microcytic	
hypochromic	anemia	 in	spite	of	normal	 iron	status.	 In	this	study,	a	cohort	of	37	patients	that	
remained	 uncharacterized	 at	 the	 Hematology	 and	 Molecular	 Department	 of	 the	 Sir	 Charles	
Gairdner	 Hospital	 in	 Nedlands,	 Australia,	 were	 evaluated	 by	 MLPA.	 The	 cohort	 consisted	
of	 two	 groups.	 The	first	 group	of	 16	patients	 showed	moderate	 anemia	 and	 clear	microcytic	
hypochromic	parameters,	normal	HbA2	and	HbF	fractions	and	normal	iron	levels,	indicative	for	
a-thalassemia	or	mild	b+-thalassemia.	The	second	group	of	21	patients	presented	with	normal	









	 All	 patients	were	 screened	 for	 deletions	 in	 the	a-	 and/or	b-globin	 gene	 clusters	 by	
MLPA.	A	 total	 number	 of	 27	 patients	was	 found	 to	 carry	 17	 different	 deletions.	 A	 schematic	
overview	of	all	deletions	is	shown	in	Figure	1.
	 In	9	patients	no	mutation	was	found	which	could	explain	the	hematological	parameters,	
including	 a	 g-globin	 triplication	 (#14)	 and	 heterozygosity	 for	 the	 African	 polymorphism	
(HBA2:c.301-24delGinsCTCGGCCC)	(#23).
	 Three	individuals	(#10,	#11	and	#12)	showed	the	same	type	of	deletion	in	the	a-globin	
gene	 cluster,	 ranging	 from	probe	10a	 to	 probe	15a	 (Fig.	 1A),	 thereby	deleting	both	a-genes. 
The	exact	 breakpoint	 of	 this	 deletion	was	determined	by	 long-range	PCR,	 restriction	enzyme	
analysis	 and	direct	 sequencing	 (described	below	 in	 detail).	 Two	 cases	 (#13	 and	 #14)	 showed	
a	slightly	larger	deletion	in	the	a-globin	gene	cluster,	ranging	from	probe	10a	to	16a	(Fig.	1B).	





	 Deletions	 involving	 the	b-gene	alone	were	 found	 in	7	 cases.	One	patient	 (#20)	with	
































	 Three	 unrelated	 individuals	 (#10,	 #11	 and	 #12)	 of	 different	 ethnic	 origin	 showed	
a	 deletion	 of	 probes	 10a-15a	 in	 the	 a-globin	 gene	 cluster	 (Fig.	 1A),	 indicating	 the	 deletion	
breakpoint	 region	 between	 probes	 9a	 and	 10a	 at	 the	 5’	 end	 and	 between	 probes	 15a	 and	
16a	at	the	3’end.	A	similar	deletion	was	previously	found	in	a	Dutch	individual	of	mixed	ethnic	
backgrounds,	described	as	--GB	by	Harteveld	et	al.	[11].	A	3	kb	breakpoint	fragment	was	obtained	
by	 PCR	 with	 primers	 10-15F	 and	 10-15R	 (Table	 2)	 for	 the	 three	 Australian	 and	 the	 Dutch	























	 Case	 #37	 was	 initially	 suspected	 to	 have	 a-thalassemia,	 because	 of	 normal	 HbA2 
level.	However,	no	mutation	or	deletion	was	found	in	the	a-globin	gene	cluster.	Large	deletions	






with	 normal	 HbA2	 level	 [21].	 Other	 types	 of	 mutations	 in	 the	 poly-A	 signal	 of	 the	 b-globin	
gene	 are	 associated	 with	 elevated	 or	 borderline-elevated	 HbA2	 level,	 which	 could	 therefore	
be	misdiagnosed	 as	a-thalassemia.	 It	 is	 therefore	 important	 to	 perform	 extensive	molecular	
research	of	both	the	a-	and	b-globin	gene	clusters	in	these	particular	cases.	
MLPA











































	 The	 16.7	 kb	 --GB	 deletion	 (Fig.	 1A),	 previously	 reported	 [11]	 and	 now	 characterized	








	 Two	new	types	of	MCS-R	deletions	were	found	 in	cases	#17	and	#18.	 In	the	~3.5	kb	
PCR	product	obtained	 from	case	#17,	 a	 39	bp	 ‘orphan	 sequence’	was	 found,	which	 is	 not	of	
human	origin	or	any	other	species	described	in	the	UCSC	Genome	Browser	and	NCBI	databases.	
The	 3’	 breakpoint	 is	 located	within	 an	 Alu	 repeat	 area;	 however,	 the	 5’	 breakpoint	 and	 the	
region	 surrounding	 the	 breakpoint	 are	 not	 located	 in	 a	 repetitive	 sequence.	 Furthermore,	
alignment	of	both	sequences	show	poor	similarity,	indicating	that	this	deletion	event	might	have	
occurred	due	 to	a	non-homologous	break	and	 ligation.	Both	breakpoint	ends	of	 the	deletion	
in	case	#18	are	located	within	an	Alu	repeat	sequence.	The	areas	surrounding	the	breakpoint	
























conditions	 are	 not	 usually	 associated	 with	 microcytosis.	 Furthermore,	 b-thalassemia	 caused	
96
by	mutations	 in	 unlinked	erythroid	 specific	 transcription	 factors	 [30]	might	 lead	 to	 increased	




































































































Fine-tiling array CGH to improve diagnostics for a- and 
b-thalassemia rearrangements
Phylipsen M, Chaibunruang A, Vogelaar IP, Balak JR, Schaap RA, 
Ariyurek Y, Fucharoen S, den Dunnen JT, Giordano PC, 





	 Implementation	 of	 multiplex	 ligation-dependent	 probe	 amplification	 (MLPA)	 for	
thalassemia	 causing	 deletions	 has	 lead	 to	 the	 detection	 of	 new	 rearrangements.	 Knowledge	
of	 the	 exact	 breakpoint	 sequences	 should	 give	more	 insight	 into	 the	molecular	mechanisms	
underlying	these	rearrangements,	and	would	facilitate	the	design	of	gap-PCRs.	
	 We	 have	 designed	 a	 custom	 fine-tiling	 array	 with	 oligonucleotides	 covering	 the	
complete	 globin	 gene	 clusters.	 We	 hybridized	 27	 DNA	 samples	 containing	 newly	 identified	
deletions	and	nine	positive	 controls.	We	designed	 specific	primers	 to	 amplify	 relatively	 short	
fragments	containing	the	breakpoint	sequence	and	analyzed	these	by	direct	sequencing.	
	 Results	 from	 nine	 positive	 controls	 showed	 that	 array	 comparative	 genomic	









	 Thalassemias	 are	 hereditary	 microcytic	 hypochromic	 anemias	 characterized	 by	
abnormalities	 in	 hemoglobin	 production	 due	 to	 absent	 or	 reduced	 expression	 of	 either	 the	
b-globin	 gene	 (HBB,	MIM#	 141900),	 leading	 to	b-thalassemia,	 or	 the	a-globin	 genes	 (HBA1,	
MIM#	 141800	 and	 HBA2,	 MIM#	 141850),	 giving	 rise	 to	 a-thalassemia.	 The	 majority	 of	 all	
a-thalassemias	 (~80-90%	 of	 cases)	 is	 caused	 by	 genomic	 deletions	 involving	 the	 a-globin	


























	 The	 standard	 method	 to	 characterize	 such	 rearrangements	 is	 to	 randomly	 design	
primers	in	the	breakpoint	region	and	perform	PCR	across	the	breakpoint.	The	breakpoint	region	
is	determined	by	the	most	proximal	and	most	distal	MLPA	probe	still	present	and	the	first	probe	











to	 search	 for	 copy	number	 variation.	 The	high	 resolution,	 simplicity,	high	 reproducibility,	 and	











the	 increasing	 importance	 of	 fine-tiling	 array	 technology	 as	 a	 follow-up	 after	 MLPA	 for	 the	
delineation	of	deletions	and	breakpoints	in	common	and	rare	rearrangements.











	 The	patient	 cohort	 consisted	of	 36	 selected	 thalassemia	patients	 of	 different	 ethnic	
backgrounds.	They	were	referred	to	our	laboratory	for	hematological,	biochemical,	and	molecular	
analysis.	Hematologic	parameters	were	determined	on	Micros	60	(SBX	Diagnostics,	Montpellier,	
France).	 Biochemical	 analysis	 was	 performed	 on	 HPLC	 VARIANT	 II	 (Bio-Rad	 Laboratories,	
Hercules,	 CA)	 using	 the	 b-Thalassaemia	 Short	 Programme,	 and	 on	 the	 Capillarys	 capillary	
electrophoresis	(CE)	device	(Sebia,	Evry,	France).	Presence	of	cellular	inclusions	of	hemoglobin	

















Arrays	User’s	Guide:	CGH	Analysis	 v4.0).	 In	brief,	 500	ng	of	 sonicated	DNA	was	denatured	 in	



































	 The	 a-	 and	 b-globin	 gene	 clusters	 contain	 nonunique	 sequences,for	 example	 the	
duplicated	a-	and	g-globin	genes	and	the	Alu-	and	LINE-repeat	regions.	The	probes	on	the	array	
are	all	unique,	 in	order	to	 increase	specificity	and	to	prevent	false	positive	results.	Therefore,	





Figure 1	 Schematic	overview	of	 the	coverage	of	 the	probes.	The	vertical	grey	 lines	 indicate	where	







clear	microcytic	hypochromic	anemia	and	normal	 iron	 levels.	Sequence	analysis	of	 the	globin	



































for	 the	HPFH-2	deletion	showed	a	difference	of	405	and	1094	bp	at	 the	5’	and	3’	end	of	 the	



















































genes.	 Sequence	 analysis	 of	 the	 breakpoint	 fragment	 revealed	 that	 these	 patients	 carry	 the	
--Dutch	I	deletion	(Harteveld	et	al.,	1997).	A	similar	but	slightly	different	deletion	of	31	kb	was	found	
in	cases	12	and	13.	Direct	sequencing	of	 the	breakpoint	 fragment	confirmed	presence	of	 the	
--MedII	deletion(Kutlar	et	al.,	1989).	A	rearrangement	of	28,073	bp	was	found	in	case	14.	Sequence	
analysis	showed	a	23	bp	overlap	between	the	5’	end	and	3’	end	breakpoint.	The	5’	end	breakpoint	
is	 located	at	position	145374	and	 the	3’	end	at	position	173447.	This	 type	of	 rearrangement	
involves	both	α-globin	genes	and	was	not	described	before.	We	named	this	deletion	--JB,	after	










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	 A	 total	of	16	unknown	b-thalassemia	deletion	carriers	were	hybridized	 to	 the	array.	
The	36415	bp	deletion	in	case	21	appeared	to	be	de novo	and	involves	the	Locus	Control	Region	






















 Upstream	primer	5'	>	3' Downstream	primer	5'	>	3' Product	size	(bp)
Dutch	I GCCAAGATCGCATCACTGTA TTGGTGTCCGGCTTCTTTTA ~550
Med	II GCCAAGATCGCATCACTGTA TTGGTGTCCGGCTTCTTTTA ~900
--JB CACCTCCCTGATAGGCAAAA TCACCACCACCTGTGTAGGA ~2500
--SA GCTGCGAATTTAACCGTATCA TCTCGCCAAAGATGGCTACT ~1400
Dutch	VII CATGTCAGGAACAGCAAGGA TGTGCTGGAATACGTGGCTA ~3000
Dutch	IV TGAATCAGCAGGCAGGATAC TTACTATATCCTACCTCTGGTATCAA ~3000
Chinese CCACATCCCTAACACAACAAAAT CTAATCCACAGTACCTGCCAAAG ~2200
Indian AATCATATTGTCCAGGGCTTTTT CTTGTGGATGCCTAAGAAAGTGA ~1200
HPFH-3 CTTTGCAATTGGATTGTTTGTTT CCAGCATCCTGAACCTCTAAGTA ~2500





















positive	 control	 samples	 and	 27	 patients’	 DNA	 samples	 were	 analyzed.	 All	 rearrangements,	
previously	 detected	 by	 MLPA,	 were	 successfully	 detected	 by	 the	 array.	 Moreover,	 a	 further	
refinement	of	the	breakpoints	was	obtained	by	the	results	of	the	array.	Furthermore,	we	were	
able	to	determine	the	exact	breakpoint	location	in	12	cases,	of	whom	two	were	carrier	of	novel	
types	 of	 deletions.	 In	 addition,	 five	 novel	 types	 of	 deletions	were	 found	 of	 which	 the	 exact	
breakpoint	 could	 not	 be	 determined	 due	 to	 the	 presence	 of	 repetitive	 sequences	 impairing	
sequence	analysis	and	proper	primer	design.


























and	 they	were	 therefore	 not	 further	 investigated.	 Other	 additional	 rearrangements	 found	 in	
the	patients	were	reported	in	the	database	of	genomic	variants	and	were	considered	clinically	
irrelevant	as	well.
	 The	 array	 used	 in	 this	 study	 is	 suitable	 to	 accurately	 detect	 small	 and	 large	
rearrangements	 in	 the	 globin	 gene	 clusters,	 as	 well	 as	 deletions	 in	 the	 upstream	 regulatory	





































	 For	 now,	 diagnostic	 application	 of	 the	 aCGH	 technology	 is	 too	 expensive,	 it	 costs	
approximately	€	90,-	per	patient	versus	approximately	€	12,-	per	patient	for	MLPA	(reagents	only,	
excluding	purchase	of	 the	 required	 instruments).	However,	 our	 results	 suggest	 that	 this	 fine-
tiling	aCGH	technology	is	a	valuable	tool	for	high	resolution	breakpoint	characterization	in	a-	and	
b-globin	gene	cluster	rearrangements.	The	delineation	of	breakpoints	will	further	improve	our	




















































































































































Two new beta-thalassemia deletions compromising 
prenatal diagnosis in an Italian and a Turkish couple 
seeking prevention
Phylipsen M, Amato A, Cappabianca MP, Traeger-Synodinos J, 
Kanavakis E, Basak N, Galanello R, Tuveri T, Ivaldi G, 





	 When	 the	molecular	background	of	 couples	 requesting	prevention	 is	unclear,	 family	
analysis	and	tools	to	define	rare	mutations	are	essential.	We	report	two	novel	deletion	defects	
observed	 in	 an	 Italian	 and	 in	 a	 Turkish	 couple.	 The	 first	 proband	 presented	 with	microcytic	
hypochromic	parameters	without	iron	deficiency,	a	normal	HbA2	and	an	elevated	HbF	(10.6%).	
His	father	presented	with	a	similar	phenotype	and	his	wife	was	heterozygous	for	the	common	
Mediterranean	 codon	 39	 (HBB:c.118C>T)	 mutation.	 Having	 excluded	 point	 mutations	 and	
common	deletions,	Multiplex	Ligation-dependent	Probe	Amplification	was	performed	revealing	
an	 unknown	 Gg(Agdb)0-thalassemia	 defect	 spanning	 from	 the	 Ag	 gene	 to	 downstream	 of	 the	
b-globin	 gene	 provisionally	 named	 Leiden 69.5 kb deletion.	 	 In	 the	 second	 case,	 the	 wife	
presented	with	a	mild	thalassemic	picture,	normal	HbA2,	elevated	HbF	(18.5%)	and	a	b/a	globin	
chain	synthesis	ratio	of	0.62,	without	iron	deficiency	or	any	known	b-thalassemia	defect,	while	











mutations	 with	 elevated HbF b-globin	 gene	 deletions	 might	 result	 in	 mild	 or	 intermediate	
phenotypes.	 However,	 combinations	with	 deletions	 involving	 both	 g-globin	 genes	may	 result	
















	 Hematologic	 data	 were	 obtained	 on	 several	 different	 occasions	 using	 the	 locally	
available	standard	protocols.	Separation	of	the	Hb	fractions	and	measurement	of	the	HbA2	and	
HbF	 levels	were	obtained	 from	different	 automatic	high	performance	 liquid	 chromatographic	
(HPLC)	devices	(1).	Globin	chain	synthesis	was	performed	in	Cagliari	using	a	modified	procedure	





































Individuals I-1 I-2 II-1 II-2* I-1** I-2
Age/Gender 60/F 68/M 32/F 34/M 30/F 44/M
Hb	(g/dL) 13.6 13.3 10.8 12.4 12.4 13.1
PCV	(l/L) 0.41 0.43 0.34 0.38 0.37 0.39
RBC	(x1012/L) 4.68 6.47 5.22 6.07 5.21 6.43
MCV	(fL) 88 67 64 63 70.8 64.4
MCH	(pg) 29.2 20.6 20.6 20.5 23.8 20.41
Ferritin	(ng/mL) n.d 202 56 154 5.52 n.d.
ZPP	(mmol/mol) n.d. n.d. n.d. n.d. 88 n.d.
HPLC A-A2 A-F-A2 A-A2 A-F-A2 A-F-A2 A-A2
HbA2	% 2.7 2.9 6.1 3.2 2.7 5.2
HbF	% 0.5 4.2 0.5 10.6 18.5 <1
b/a	ratio n.d. n.d. n.d. n.d. 0.62 n.d.




	 Deletion	 defects	 affecting	 the	 b-globin	 gene	 cluster,	 associated	 with	 a	 high	 HbF	
expression	in	adult	life,	are	usually	subdivided	in	two	categories.	This	distinction	is	purely	clinical	
and	 based	 on	 the	 observation	 of	 the	 hematologic	 indices	 of	 the	 specific	 cases.	 Those	 cases	
with	(near)	normal	hematological	indices	are	defined	as	HPFH,	those	presenting	with	abnormal	
indices	as	db-thalassemia.	






















g-globin	genes,	which	 is	 common	to	 several	HPFH	and	 Gg(Agdb)0-thalassemia	deletion	defects,	
such	as	the	Indian	(32.6	kb)	and	the	Turkish	(30	kb)	HPFH,	as	well	as	the	Indian	(8.5	kb),	the	Black	
(35.7	kb),	the	Belgian	(50	kb)	and	the	Italian	(52kb)	Gg(Agdb)0-thalassemia	defects.	
	 The	 new	 deletion	 was	 associated	 with	 the	 expected	 microcytic	 hypochromic	
parameters	of	a	Gg(Agdb)0-thalassemia	defect	because	the	HbF	expression,	in	the	absence	of	the	






















area.	 The	deletion	 reduces	 the	 level	 of	 the	HbA2	 to	 normal	 and	elevates	 the	HbF	 expression	















the	 point	 mutation.	 In	 the	 second	 case,	 an	 apparent	 favorable	 heterozygosity	 could	 cause	
a	misdiagnosis.	 Finally,	 the	 prediction	 of	 phenotype	 remains	 a	 complex	matter.	 It	 cannot	 be	
guaranteed	 that	 a	 child	with	a	 combination	b0	 /	 Gg(Agdb)0	will	 be	healthy	and	able	 to	 survive	
without	hematologic	complications	and	without	blood	transfusions.
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Non-invasive prenatal diagnosis of beta-thalassemia and 
sickle-cell disease using pyrophosphorolysis-activated 
polymerization and melting curve analysis
Phylipsen M, Yamsri S, Treffers EE, Jansen DT, Kanhai WA, Boon EM, 





	 Objective:	 The	 aim	 of	 this	 study	 was	 to	 develop	 a	 pyrophosphorolysis-activated	
polymerization	 (PAP)	assay	 for	non-invasive	prenatal	diagnosis	 (NIPD)	of	b-thalassemia	major	






























for	 fetal	 sex	 determination,	 RhD	 genotype	 and	 trisomy	 21	 detection	 (8-12).	 Free	 fetal	 DNA	
(ffDNA)	is	detectable	very	early	during	pregnancy	and	the	average	amount	of	cell	ffDNA	during	
the	first	and	second	trimester	is	~10%	of	the	total	amount	of	cell-free	DNA	(13).
	 Recently,	 the	 pyrophosphorolysis-activated	 polymerization	 (PAP)	 technique	
was	 successfully	 applied	 in	 fetal	 sex	 determination	 (14).	 Because	 of	 the	 serial	 coupling	 of	
pyrophosphorolyis	 and	polymerization,	 this	 reaction	has	 a	 very	high	 specificity	 (one	mutated	
allele	can	be	detected	in	109	wildtype	alleles)	(15;16).	PAP	uses	oligonucleotides	with	a	blocked	
3’	end,	which	can	only	be	removed	(and	thus	permitting	extension)	when	they	anneal	to	specific	
sequences	of	 target	DNA.	 It	has	been	shown	that	 if	a	mismatch	occurs	within	16	nt	 from	the	
3’-terminus	of	 the	PAP-primer,	amplification	 is	 still	 inhibited	 (17).	 In	 this	way,	 it	 is	possible	 to	
132
specifically	 amplify	 DNA	 inherited	 from	 father	 by	 using	 paternally	 specific	 mutations	 or	
polymorphisms	that	are	absent	in	mother.	
	 The	aim	of	 the	current	 study	was	 to	develop	a	PAP	assay	 for	NIPD	of	b-thalassemia	




















studies	 (20;21)	 (Table	1).	DNA	samples	 from	healthy	 individuals	of	 seven	 subsets	of	different	
populations	were	genotyped	by	MCA	 to	 test	 their	 informativity.	These	 included	50	Dutch,	50	
Czech,	20	Turks,	20	Moroccans,	20	Greek,	20	Cypriots	and	30	Surinamese	individuals.	Thirteen	
pregnant	couples	referred	to	our	laboratory	for	carrier	diagnostics	were	randomly	selected	and	






























Nijmegen,	 The	Netherlands),	 1	 unit	GoTaq	 polymerase	 (Promega,	Madison,	WI,	USA)	 and	 20	





(Roche),	 0.2	mM	 dNTPs	 (Roche),	 1	mM	 forward	 primer,	 10	mM	 reverse	 primer,	 5	mM	 probe	
(Biolegio),	1	mL	LCGreen®	Plus	dye	(Idaho	Technology	Inc.,	Salt	Lake	City,	UT,	USA),	1	unit	FastStart	
Taq	 polymerase	 (Roche)	 and	 20	 ng	 genomic	 DNA.	 In	 case	 of	 the	 nested	 PCR,	 1:100	 diluted	
external	PCR	product	was	used	instead	of	genomic	DNA.	The	PCR	was	performed	in	a	4Titude	
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Test cases: 13 pregnant couples 
















Proof of principle: retrospective NIPD
	 A	Turkish	couple	at	risk	for	SCD	was	referred	to	our	clinic	for	prenatal	diagnosis	for	their	
second	pregnancy.	Their	first	child	was	born	unaffectedly.	We	performed	MCA	for	both	parents	
























the	HbS	mutation.	Therefore,	 it	can	be	concluded	that	the	C	 is	 linked	to	the	normal	allele	 [normal	
(p)].	The	C	allele	was	detected	in	the	maternal	plasma,	indicating	that	the	second	child	also	inherited	
the	normal	 paternal	 allele	 and	will	 thus	not	be	 affected	with	 sickle-cell	 disease.	 (B) Results	 of	 gel	



















markers,	 and	 the	 sensitivity	 of	 the	 PAP	 assay	 is	 necessary	 for	 detection	 of	 the	 ffDNA.	 The	
PAP	assay	can	be	performed	in	1	day,	so	the	complete	NIPD	can	be	performed	within	2	days.
	 A	 limitation	 of	 using	 linkage	 for	NIPD	 is	 the	 requirement	 of	 a	 previously	 born	 child	
or	 other	 family	 member	 to	 determine	 the	 phase	 of	 the	 paternal	 mutation	 in	 combination	
with	 the	 SNP.	 However,	 the	 number	 of	 requests	 for	 prenatal	 diagnosis	 is	 increasing	 due	 to	






recombination	between	the	d-globin	and	b-globin	genes	 (20).	 In	previous	studies,	 the	rate	of	
recombination	in	the	b-globin	gene	cluster	is	estimated	to	be	3	to	30	times	(25)	and	30	to	50	
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major	and	SCD,	provided	that	a	previously	born	child	or	other	 family	member	 is	available	 for	
testing	to	determine	the	linkage	to	the	paternal	SNPs.	If	the	SNP	linked	to	the	paternal	mutation	
is	detected,	an	invasive	procedure	will	still	be	necessary	to	check	whether	the	fetus	also	inherited	
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A new a0-thalassemia deletion found in a 
Dutch family (--AW)
Phylipsen M, Vogelaar IP, Schaap RA, Arkesteijn SG, Boxma GL, 
van Helden WC, Wildschut IC, de Bruin-Roest AC, 
















	 Thalassemias	 are	 inherited	 hemoglobin	 disorders	 characterized	 by	 a	 quantitative	






	 Multiplex	 Ligation-dependent	 Probe	 Amplification	 (MLPA)	 (1)	 is	 a	 relatively	 simple	
technique	 for	 rapid	detection	of	genomic	rearrangements	 in	 the	a-globin	gene	cluster.	 It	was	
previously	shown	that	this	assay	is	suitable	to	detect	known	and	unknown	deletions	in	a	cohort	
of	cases	that	remained	unsolved	after	performing	the	standard	diagnostic	techniques	(2).	Here	




	 Fresh	 blood	 samples	 of	 6	 members	 of	 a	 Dutch	 family	 (Fig.	 1)	 were	 analyzed	 using	
standard	methods.	All	members	agreed	to	participate	in	this	study	by	written	informed	consent.	








TaqTM	kit,	TaKaRa	Bio	 Inc,	Otsu,	Shiga,	 Japan)	was	performed	according	 to	 the	manufacturer’s	






















which	 allowed	 the	 design	 of	 sequencing	 primer	 AW-Rseq	 close	 to	 the	 breakpoint.	 Sequence	











probe	 numbers	 refer	 to	 the	HBA	 probe	mix	 (Service	





I.1 II.1 II.2 II.3 III.1 III.2
Age-sex 82-F 61-M 57-F 55-F 34-F 29-M
Hb	(g/dL) M:	13.7-17.7
F:	12.1-16.1
8.5 14.7 13.0 13.2 13.5 15.3
RBC	(1012/L) M:	4.6-6.2
F:	4.2-5.4
4.33 6.88 5.94 4.58 4.55 7.02
MCV	(fL) 76-100 69 71 72 89 89 73
MCH	(pg) 27.4-33.8 19.8 21.4 22.1 28.7 29.8 21.7
HbA2	(%) 2.2 2.4 2.1 2.4 2.5 2.2
HbF	(%) 1.3 0.6 0.7 0.5 0.6 0.4
HbH N.D. + + N.D. N.D. +
ZPP	(mmol	ZP/mol	heme) <	100 122 45 62 74 46 56
Haptoglobin	(mg/100	mL) 50-180 133 110 110 68.1 78 93.6
Hematocrit M:	0.40-0.53
F:	0.36-0.48
0.298 0.488 0.425 0.409 0.403 0.512
Gap-PCR	a Normal Normal Normal Normal Normal Normal






























Figure 3	Breakpoint	 fragment	of	 the	 --AW	deletion.	The	14	bp	orphan	sequence	 is	 indicated	by	 the	
red	square.	The	first	 (C)	and	 last	 (T)	nucleotide	of	the	orphan	sequence	overlap	with	the	5’	and	3’	
breakpoint	sequence,	respectively.	The	unknown	base	pair	substitution	(G>A)	is	indicated	by	the	arrow.
	 Alu	 and	 L1	 sequences,	 which	 are	 present	 at	 more	 than	 500,000	 locations	 of	 the	
human	genome,	are	the	two	most	common	repeat	elements	identified,	representing	more	than	
5%	and	10%		of	the	human	genome,	respectively	 (7).	Non-homologous	recombination	events	






































































A novel a0 -thalassemia deletion in a Greek patient 
with HbH disease and b-thalassemia trait
Phylipsen M, Traeger-Synodinos J, van der Kraan M, van Delft P, 
Bakker G, Geerts M, Kanavakis E, Stamoulakatou A, Karagiorga M, 







 Methods:	 Standard	 hematology,	 Hb	 electrophoresis,	 and	 HPLC.	 Multiplex	 ligation-
dependent	probe	amplification	(MLPA),	direct	sequencing,	and	breakpoint	characterization	by	
NimbleGen	fine-tiling	array	analysis.	
 Results:	 The	 index	patient	 showed	a	moderate	microcytic	hypochromic	anemia	with	



























	 A	 Greek	 child	 with	 a	 moderate	 microcytic	 hypochromic	 anemia	 suspected	 to	 have	





	 This	 study	 shows	 the	 benefit	 of	 combining	 hematological	 analysis	 with	 advanced	
molecular	techniques	like	MLPA	and	array	comparative	genome	hybridization	(aCGH)	to	detect	





	 The	 propositus,	 a	 child	 of	 Greek	 origin,	 presented	 at	 2.5	 yr	 old	 with	 a	 moderate	





	 The	hematological	 indices	were	obtained	on	 an	 automatic	blood	 counter,	 in	Athens	




Gap-PCR and Direct sequencing 
	 Genomic	DNA	was	purified	from	leucocytes	using	the	Qiagen	AutoPure	LSTM	Genomic	
DNA	 Purification	 System	 (Gentra	 Systems	 Inc.,	 Minneapolis,	 MN,	 USA)	 according	 to	 the	
manufacturer’s	 instructions.	 Modified	 gap-PCR	 was	 used	 to	 screen	 for	 the	 seven	 	 common	
a-thalassemia	deletions	(-a3.7,	-a4.2,	--MED-I,	-(a)20.5,	--SEA,	--THAI,	--FIL)	(7;8).	
	 For	point	mutation	analysis	of	 the	a	 genes,	 PCR	was	performed	on	a	T-Professional	
thermal	 cycler	 (Biometra,	 Göttingen,	 Germany)	 using	 the	 Qiagen®	 Multiplex	 PCR	 kit	
(cat.no.206143).	 For	 sequence	 analysis,	 the	 a-globin	 genes	 were	 amplified	 using	 a2- 
and	 a1-specific	 primers	 (S13F	 5’-tgtaaaacgacggccagtcgccagccaatgagcgcc-3’	 and	 S6R	

























areas	 was	 designed	 (Roche	 NimbleGen,	 Madison,	 WI,	 USA)	 (19).	 Sample	 preparation,	 array	





3’->5’exo-	 (New	England	Biolabs,	 Ipswich,	MA,	USA),	 for	2	h	at	37oC.	After	washing,	each	 test	
sample	and	corresponding	reference	sample	were	mixed	and	dried	in	a	SpeedVac.	Pellets	were	
resuspended	 in	Sample	Tracking	Controls	 (NimbleGen).	After	mixing	 the	 resuspended	 sample	
with	 the	 hybridization	 solution	 (containing	 Hybridization	 Buffer,	 Hybridization	 Component	 A	
and	an	Alignment	Oligo,	all	from	NimbleGen),	the	samples	were	loaded	onto	the	array.	Samples	




Primer design and breakpoint PCR 











sequence	 (5’-GGTTAGAAAGTTTATGTGAACGGGT-3’),	 however,	 sequencing	 failed	 repeatedly	






red	 blood	 cells,	 suggested	 a	 coexisting	 a-thalassemia,	 although	 HbH	 was	 not	 detected	 by	
chromatography	or	electrophoresis.
162
Patient Mother Father Propositus Normal	range
age 2.5	yr
Hb	(g/dL) 11.9 15 8.6 m:	14-18,	f:	12-16
Hct	(%) 41.8 47 33 m:	42-52,	f:	37-47
MCV	(fL) 76.5 87.9 52.3 80-97
MCH	(pg) 21.8 28.1 13.7 27-33.8
HbA2	(%) 5.6 2.6 4.6 2.2-3.2
HbF	(%) 0 0 1.8 <0.5
RDW 15.5 14.5 18.5 11-14
Retics	(%) n.d. n.d. 0.8 0-2
I.B. + - ++ -
DNA	a-genes aa/--BGS a(-5nt)a/aa1 a(-5nt)a/--BGS aa/aa







the	 common	 non-deletion	 a-thalassemia	 allele	 a2	 IVS1(-5nt)	 (HBA2c.95+2_95+6delTGAGG)	
appearing	as	hemizygous,		from	the	father.	The	a0-thalassemia	deletion,	investigated	by	MLPA,	




	 Fine	 mapping	 using	 a	 fine-tiling	 array	 of	 overlapping	 primers	 covering	 the	 region	
of	unique	 sequences	 from	 the	 telomere	of	 chromosome	16	 to	approximately	2	Mb	 from	 the	
telomere	suggests	an	interstitional	deletion	leaving	the	telomeric	region	intact.	The	5’	deletion	
breakpoint	 is	 located	 within	 the	 POLR3K	 gene,	 close	 to	 the	 telomere	 (Fig.	 1),	 while	 the	 3’	
breakpoint	maps	between	the	a1-	and	q-genes	(HBA1	and	HBQ1,	respectively),	a	region	known	
to	be	rich	 in	Alu	repeats.	Primer	design	as	close	to	the	breakpoint	as	possible	was	hampered	
by	 the	 lack	of	unique	sequences	due	to	stretches	of	Alu	 repeats.	The	best	option	rendered	a	
breakpoint	PCR	fragment	of	approximately	1200	bp.	Sequence	analysis	from	the	3’	end	showed	
514	 bp	 located	 from	 position	 169679-	 169165	 (according	 to	 the	 UCSC	 Genome	 Browser	 on	
Human	Mar.	2006	(NCBI36/hg	18)	Assembly	database)	between	the	a1-globine	gene	and	q-gene 






breakpoint	 fragment	 and	 the	 mapping	 of	 sequences	 in	 BLAT	 to	 the	 genomic	 sequence,	 the	
remaining	300	bp	coincide	with	the	Alu	repeat	flanking	the	5’	breakpoint	sequence	at	position	
37871,	where	the	poly-A	stretch	hampers	further	sequence	analysis.	













undetected	 by	 routine	molecular	 screening	 by	 gap-PCR	 for	 the	most	 common	a-thalassemia	
deletions,	which	subscribes	the	importance	for	interpretation	of		molecular	results	in	the	context	
of	the	patient’s	phenotype.	In	the	presently	described	case,	the	hematological	phenotype	could	
not	 be	 explained	 by	 homozygosity	 for	 the	 observed	 a2(-5nt)	 mutation.	 The	 introduction	 of	
MLPA	as	a	diagnostic	screening	tool	has	improved	laboratory	diagnostics	for	unknown	deletions	
(10;17;18).	Alternatively,	characterization	of	the	breakpoints	is	necessary	to	design	primers	for	
gap-PCR	 as	 a	 simple	 and	 fast	 screening	 tool	 for	 the	molecular	 diagnosis	 of	 known	deletions.	
The	 design	 of	 new	 deletion-specific	 oligo-primers	 for	 gap-PCR	 and	 breakpoint	 sequence	






















and	 more	 pronounced	 microcytic	 hypochromic	 parameters.	 The	 association	 of	 HbH	 and	
b-thalassemia	trait	does	not	lead	to	a	reduction	of	HbA2	in	such	a	way	that	laboratory	diagnosis	of	
b-thalassemia	is	altered.	On	the	other	hand,	the	hematological	findings	in	the	propositus	carrying	
the	HbH/b-thal	 trait	genotype	are	almost	 indistinguishable	 from	those	 found	 in	 iron-deficient	
b-thalassemia	heterozygotes	and	may	confound	the	diagnosis	when	parents	are	not	available		(31).
	 The	absence	of	 free	b-globin	chains	and	 thus	detectable	non-functional	HbH	means	








a	breakpoint	 located	between	position	167,500	and	176,000	 (a1-globin	 gene	and	 the	3’	HVR	
or	Hyper	Variable	Region,	UCSC	Genome	Browser	on	Human	Mar.	2006).	From	these,	at	 least	
12	break	between	a1-	 and	q-globin	 gene.	 This	 segment	 is	 therefore	 considered	 a	 breakpoint	
cluster	 region	 (32).	An	unusual	 feature	of	 the	described	novel	deletion	 is	 the	presence	of	an	












Figure 2 (A)	 Chromosomal	 location	 of	 the	 breakpoint	 fragments.	 Bars	 indicate	 the	 chromosomal	
regions,	 exons	 are	 indicated	 as	 filled	 blocks,	 vertical	 lines	 mark	 intronic	 sequences,	 stippled	 line	
interconnecting	the	bars	indicates	the	distance	between	the	chromosomal	regions,	and	the	telomere	






that	 the	 recombination	 occurred	when	 both	 loops	were	 geographically	 close	 during	 replication	 in	


































































































































Improvement of molecular diagnosis of hemoglobinopathies
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Molecular detection of hemoglobinopathies
	 Hemoglobinopathies	 constitute	 the	 commonest	 recessive	 monogenic	 disorders	




mutations	have	been	 reported,	most	of	which	 involve	deletions	within	 the	a-gene	cluster.	 In	
addition,	 more	 than	 1150	 mutations	 causing	 structural	 variants	 have	 been	 characterized.	
(Summarized	in	HbVar	http://globin.bx.psu.edu/hbvar/menu.html).	
	 The	most	 commonly	 used	 procedures	 for	 known	mutations	 include	 the	 reverse	 dot	
blot	analysis	with	allele	specific	oligonucleotide	probes,	 the	amplification	refractory	mutation	















	 Deletions	 causing	 thalassemia	 can	 be	 detected	 by	 Southern	 blot	 and	 fluorescent	 in	
situ	hybridization	(FISH).	These	techniques	use	radioactively	or	fluorescently	labeled	probes	to	
confirm	presence	of	a	 large	deletion	 in	the	globin	gene	cluster.	Southern	blot	analysis	 is	time	
consuming,	technically	demanding	and	success	is	very	much	dependent	upon	the	hybridization	
probes	 available.	 FISH	 analysis	 involves	 laborious	 cell	 culturing	 to	 generate	 metaphase	
chromosome	 spreads	 and	has	 a	 low	 resolution	 (>20	 kb).	 Therefore,	 an	 increasing	number	of	
laboratories	 is	 replacing	 these	 techniques	 by	 gap-PCR	 and	MLPA	nowadays.	Gap-PCR	 is	 used	
to	screen	for	the	most	common	a-thalassemia	deletions	(-a3.7,	-a4.2,	--SEA,	-(a)20.5,	--THAI,	--FIL	and	
--MedI)	 and	 the	a-globin	 gene	 triplication	 (13).	 This	 technique	provides	 a	 quick	diagnostic	 test	
for	a+-	 and	a0-thalassemia	deletion	mutations.	 It	 is	 simple,	non-radioactive	and	 little	 starting	
material	is	required.	In	addition,	gap-PCR	is	able	to	identify	~80%	of	all	a-thalassemia	carriers.	
However,	 deletions	 for	which	 no	 primers	 are	 available,	 especially	 previously	 uncharacterized	
rearrangements,	will	be	missed	by	this	procedure.





available	MLPA	probe	sets,	which	 facilitated	 the	widespread	use	of	 this	 technique.	These	kits	
contain	 MLPA	 probes	 consisting	 of	 one	 short	 synthetic	 oligonucleotide	 and	 one	 long	 probe	
oligonucleotide,	 which	 are	 generated	 by	 cloning	 target-specific	 sequences	 into	 M13	 vectors	
containing	different	lengths	of	stuffer	sequences.	The	major	disadvantage	of	this	approach	is	the	
complex,	expensive	and	time-consuming	probe	generation	procedure	(14;15).





















of	 chromosomes	 13,18,	 21	 and	 the	 sex	 chromosomes	 (22).	 Although	 the	 yield	 of	 DNA	 from	
a	chorionic	villus	or	amniotic	fluid	sample	 is	relatively	 low,	MLPA	results	are	very	reliable	and	
reproducible.	 Therefore,	 the	 laborious	 and	 time-consuming	 conventional	 karyotyping	 can	 be	
replaced	by	rapid	tests	such	as	MLPA	in	cases	suspected	of	common	chromosome	aneuploidies	


































location.	 Another	 hotspot	 of	 recombination	 is	 formed	 by	 the	 hypervariable	 region	 located	
downstream	of	 the	a-globin	gene	cluster	 (3’	HVR).	This	 region	consists	of	an	array	of	70-450	























Prenatal diagnosis of hemoglobinopathies
	 Prenatal	diagnosis	is	an	important	part	of	obstetric	care.	Conventionally,	sampling	of	fetal	
genetic	material	is	performed	by	invasive	techniques	including	amniocentesis	(AC)	and	chorionic	


















	 The	high	 frequency	 and	 severity	 of	 hemoglobin	 disorders	 lead	 to	 the	 application	of	




than	 DNA	 analysis.	 Once	 a	 carrier	 couple	 has	 been	 identified	 based	 on	 their	 hematology,	
the	underlying	mutations	must	be	 characterized	 to	be	 able	 to	 counsel	 them	on	 the	 risk	of	 a	
hemoglobin	disorder	and	to	perform	prenatal	diagnosis	if	indicated.			
	 Prenatal	 diagnosis	 using	 ffDNA	 in	 maternal	 plasma	 was	 first	 applied	 to	 the	
hemoglobinopathies	 in	 2002.	 This	 study	 described	 a	 real-time	 PCR	 assay	 to	 detect	 paternal	
inheritance	of	the	HBB:c.126_129delCTTT	mutation,	which	is	the	most	common	b-thalassemia	














imbalance	 in	mutant	 and	wild-type	 alleles,	when	 the	 fetus	 is	 homozygous	 for	 the	mutant	 or	
wild-type	allele.	This	digital	counting	approach	has	been	successfully	applied	for	NIPD	of	several	
b-thalassemia	causing	mutations	(61).	The	drawback	of	this	technique	is	that	it	is	very	laborious	
and	 time	 consuming	 to	 perform	 the	 many	 PCR	 reactions	 required	 to	 obtain	 a	 statistically	
significant	result.




makes	 it	 possible	 to	 perform	 NIPD	 in	 couples	 carrying	 the	 same	mutation.	 In	 addition,	 this	
approach	might	also	be	applicable	 for	other	genetic	disorders	as	 linkage	 to	 informative	SNPs	
can	be	used	for	most	disease	genes.	The	method	showed	to	be	reliable,	relatively	easy,	quick	
and	cheap	to	perform.	This	enables	NIPD	of	b-thalassemia	major	and	SCD	provided	a	previously	
born	 child	 or	 other	 family	 member	 is	 available	 for	 testing	 to	 determine	 the	 linkage	 to	 the	
paternal	SNPs.	If	the	SNP	linked	to	the	paternal	mutation	is	detected,	an	invasive	procedure	will	





	 Diagnostics	 for	 hemoglobinopathies	 is	 strongly	 improved	 over	 the	 recent	 years.	 In	
particular	the	implementation	of	the	MLPA	technique	made	it	possible	to	detect	deletions	and	
duplications	 in	 the	globin	 gene	 clusters	 in	patients	who	 remain	undiagnosed	by	applying	 the	












are	 investigated.	 For	 example,	 detection	 of	 fetal	 trisomies	 in	 maternal	 plasma	 by	 massive	
parallel	 sequencing	 was	 shown	 to	 be	 successful	 (63).	 Massive	 parallel	 sequencing	 has	 also	
been	performed	for	prenatal	diagnosis	of	b-thalassemia	and	it	was	shown	to	be	able	to	detect	
paternally	 inherited	mutations	 in	maternal	plasma	 (64).	These	new	 technologies	will	become	
very	important	in	the	near	future,	both	in	pre-	and	postnatal	diagnostics.	They	will	replace	the	
current	molecular	techniques	including	gap-PCR,	sequencing	analysis,	MLPA	and	aCGH.	However,	







































































































































































































































	 Hemoglobinopathies	 (HbP)	 are	 recessive	 hereditary	 disorders	 of	 hemoglobin,	






	 Because	 carriers	of	 a	HbP	are	protected	against	de	 severe	 consequences	of	malaria	
tropica,	 HbPs	 mainly	 occur	 in	 areas	 where	 malaria	 is	 or	 has	 been	 endemic,	 such	 as	 the	
Mediterranean	 area,	 the	Middle	 East	 and	 Southeast	Asia.	However,	 due	 to	 recent	migration,	
HbPs	are	also	becoming	a	health	risk	 in	the	northern	European	countries.	 It	 is	estimated	that	








	 HbP	 diagnostics	 encompasses	 three	 specialties:	 hematological,	 biochemical	 and	








































of	 recombination	 between	Alu-repetitive	 sequences	 on	 both	 alleles.	 These	 studies	 underline	
























	 Diagnostics	 for	 HbP	 is	 strongly	 improved	 over	 the	 recent	 years,	 mainly	 due	 to	
implementation	of	MLPA.	This	has	led	to	application	of	aCGH	to	determine	the	breakpoint	with	
187
higher	 resolution,	 which	 resulted	 in	 characterization	 of	 several	 deletions	 and	 duplications	 in	



















	 Doordat	 dragers	 van	 een	 Hb-pathie	 beschermd	 zijn	 tegen	 de	 ernstige	 gevolgen	








nationale	 programma’s	 geïmplementeerd	 om	 dragers	 van	 een	 Hb-pathie	 te	 identificeren	 om	
primaire	 preventie	 te	 faciliteren.	Men	 kan	 risicoparen	 dan	 een	 geïnformeerde	 reproductieve	




samen	 vormen	de	 complete	diagnose.	 In	 dit	 proefschrift	wordt	 ingegaan	op	het	 ontwikkelen	
en	 optimaliseren	 van	moleculaire	 technieken,	 zowel	 voor	 post-	 als	 prenataal	 onderzoek,	 ten	
behoeve	van	verbetering	van	de	diagnostiek	voor	Hb-pathieën.	
	 Hoofdstuk	 2.1	 beschrijft	 een	diagnostische	 test,	 gebaseerd	op	de	 gap-PCR	 techniek,	
om	acht	in	Zuidoost	Azië	veel	voorkomende	deleties	in	het	b-globine	gencluster	te	detecteren.	
Deze	techniek	is	snel,	eenvoudig,	goedkoop	en	kan	in	elk	moleculair	diagnostisch	laboratorium	
toegapast	worden.	 In	 hoofdstuk	 2.2	 beschrijven	wij	 de	 toepassing	 van	 de	multiplex	 ligation-
dependent	 probe	 amplification	 (MLPA)	 techniek	 voor	 de	 detectie	 van	 deleties	 in	 de	 a- en 
b-globine	 genclusters.	 	 In	 tegenstelling	 tot	 conventionele	 methoden	 zoals	 Southern	 blotting	
en	 fluorescente	 in-situ	 hybridisatie	 (FISH),	 is	 MLPA	 in	 staat	 om	 op	 een	 snelle	 en	 goedkope	
manier	 bekende	 en	 onbekende	 deleties	 en	 duplicaties	 te	 detecteren	 met	 een	 zeer	 hoge	
resolutie.	 Dit	 onderzoek	 laat	 zien	 dat	 de	MLPA	methode	 zeer	 geschikt	 is	 om	 deleties	 in	 de	
a- en b-globine	genclusters	 te	detecteren;	 zowel	deleties	met	bekende	breekpunten,	minder	
frequent	 voorkomende	 en	 negen	 nog	 niet	 eerder	 beschreven	 deleties	 werden	 gevonden.	
De	 toepasbaarheid	 van	MLPA	wordt	 verder	 toegelicht	 in	hoofdstuk	2.3.	 In	deze	 studie	 is	 een	









te	bepalen,	omdat	 zo	meer	 kennis	 verkregen	 zou	 kunnen	worden	over	mechanismes	die	 ten	
grondslag	liggen	aan	het	ontstaan	van	deze	deleties.








	 In	 hoofdstuk	 4.1	 wordt	 de	 --AW	 deletie	 beschreven.	 Deze	 deletie,	 gevonden	 in	 een	
Nederlandse	 familie,	 heeft	 een	 lengte	 van	 8.2	 kb	 en	 neemt	 beide	a-globine	 genen	weg.	 Na	
sequentie	 analyse	 van	 het	 breekpuntfragment	 kon	 worden	 geconcludeerd	 dat	 deze	 deletie	
waarschijnlijk	 is	 ontstaan	 door	 een	 niet-homologe	 recombinatie	 tussen	 een	 Alu-	 en	 een	 L1-
repeat.	Dit	type	recombinatie	is	zeer	zeldzaam	en	nog	niet	eerder	beschreven	in	het	a-globine	




















leidt	 tot	 thalassemie	major.	 Dit	 was	 echter	 niet	 het	 geval	 in	 de	 onderzochte	 risicoparen;	 na	
analyse	met	behulp	van	MLPA	bleek	er	sprake	te	zijn	van	een	niet	eerder	beschreven	deletie	die	
het	b-globine	gen	wegneemt.


















toegepast	 om	 de	 breekpunten	 met	 een	 hogere	 resolutie	 te	 bepalen.	 Dit	 heeft	 geleid	 tot	
karakterisatie	 van	 verschillende	 deleties	 en	 duplicaties	 in	 de	 globine	 genclusters.	 Met	 deze	














Aansluitend	 volgde	 zij	 de	 opleiding	 Biomedische	Wetenschappen	 aan	 de	Universiteit	 Leiden,	
waarvan	het	bachelor	diploma	behaald	werd	 in	2005.	De	eerste	stage	werd	uitgevoerd	op	de	
afdeling	 Parasitologie	 van	 het	 Leids	Universitair	Medisch	 Centrum	 (LUMC),	 onder	 leiding	 van	
Dr.	Elly	van	Riet	en	Prof.	Dr.	Maria	Yazdanbakhsh.	De	afstudeeropdracht	werd	verricht	bij	het	
Hemoglobinopathieën	 Laboratorium	 op	 de	 afdeling	 Klinische	 Genetica	 in	 het	 LUMC,	 onder	
leiding	van	Dr.	Piero	Giordano	en	Dr.	Kees	Harteveld.	In	2007	behaalde	ze	haar	Master	of	Science	
titel.	
	 In	 januari	2007	 is	zij	begonnen	als	onderzoeker	 in	opleiding	op	de	afdeling	Klinische	
Genetica	van	het	LUMC,	onder	leiding	van	Prof.	Dr.	Bert	Bakker	en	Dr.	Kees	Harteveld,	met	als	
onderwerp	ontwikkeling	en	verbetering	van	technieken	voor	post-	en	prenatale	diagnose	van	
hemoglobinopathieën.
	 Sinds	mei	2012	is	Marion	Phylipsen	werkzaam	als	assistent	staflid	moleculaire	genetica	
op	de	afdeling	Klinische	Genetica	van	het	Leids	Universitair	Medisch	Centrum.

List of publications

201
List of publications
Harteveld	CL,	Voskamp	A,	Phylipsen	M,	Akkermans	N,	den	Dunnen	JT,	White	SJ,	Giordano	PC.	
Nine	unknown	rearrangements	in	16p13.3	and	11p15.4	causing	alpha-	and	beta-thalassaemia	
characterised	by	high	resolution	multiplex	ligation-dependent	probe	amplification.	
J	Med	Genet.	2005	Dec;42(12):922-31.	
Harteveld	CL,	Kriek	M,	Bijlsma	EK,	Erjavec	Z,	Balak	D,	Phylipsen	M,	Voskamp	A,	di	Capua	E,	
White	SJ,	Giordano	PC.	Refinement	of	the	genetic	cause	of	ATR-16.	
Hum	Genet.	2007	Nov;122(3-4):283-92.
Bezerra	MA,	Araujo	AS,	Phylipsen	M,	Balak	D,	Kimura	EM,	Oliveira	DM,	Costa	FF,	Sonati	MF,	
Harteveld	CL.	The	deletion	of	SOX8	is	not	associated	with	ATR-16	in	an	HbH	family	from	Brazil.	
Br	J	Haematol.	2008	Jun;142(2):324-6.
Phylipsen	M,	Amato	A,	Cappabianca	MP,	Traeger-Synodinos	J,	Kanavakis	E,	Basak	N,	Galanello	
R,	Tuveri	T,	Ivaldi	G,	Harteveld	CL,	Giordano	PC.	Two	new	beta-thalassemia	deletions	
compromising	prenatal	diagnosis	in	an	Italian	and	a	Turkish	couple	seeking	prevention.	
Haematologica.	2009	Sep;94(9):1289-92.
Harteveld	CL,	Oosterhuis	WP,	Schoenmakers	CH,	Ananta	H,	Kos	S,	Bakker	Verweij	M,	van	Delft	P,	
Arkesteijn	SG,	Phylipsen	M,	Giordano	PC.	Alpha-thalassaemia	masked	by	beta	gene	defects	and	
a	new	polyadenylation	site	mutation	on	the	alpha2-globin	gene.	
Eur	J	Haematol.	2010	Apr;84(4):354-8.
Phylipsen	M,	Prior	JF,	Lim	E,	Lingam	N,	Vogelaar	IP,	Giordano	PC,	Finlayson	J,	Harteveld	CL.	
Thalassemia	in	Western	Australia:	11	novel	deletions	characterized	by	Multiplex	Ligation-
dependent	Probe	Amplification.	
Blood	Cells	Mol	Dis.	2010	Mar	15;44(3):146-51.
Al-Saqladi	AW,	Brabin	BJ,	Bin-Gadeem	HA,	Kanhai	WA,	Phylipsen	M,	Harteveld	CL.	Beta-globin	
gene	cluster	haplotypes	in	Yemeni	children	with	sickle	cell	disease.	
Acta	Haematol.	2010;123(3):182-5.
Phylipsen	M,	Prior	JF,	Lim	E,	Lingam	N,	Finlayson	J,	Arkesteijn	SG,	Harteveld	CL,	Giordano	PC.	
Two	new	alpha1-globin	gene	point	mutations:	Hb	Nedlands	(HBA1:c.86C>T)	[alpha28(B9)Ala--
>Val]	and	Hb	Queens	Park	(HBA1:c.98T>A)	[alpha32(B13)Met-->Lys].	
Hemoglobin.	2010	Jan;34(2):123-6.
Phylipsen	M,	Gallivan	MV,	Arkesteijn	SG,	Harteveld	CL,	Giordano	PC.	Occurrence	of	common	
and	rare	d-globin	gene	defects	in	two	multiethnic	populations:	thirteen	new	mutations	and	the	
significance	of	d-globin	gene	defects	in	b-thalassemia	diagnostics.	
Int	J	Lab	Hematol.	2011	Feb;33(1):85-91.	
202
Phylipsen	M,	Vogelaar	IP,	Schaap	RA,	Arkesteijn	SG,	Boxma	GL,	van	Helden	WC,	Wildschut	IC,	de	
Bruin-Roest	AC,	Giordano	PC,	Harteveld	CL.	A	new	alpha0-thalassemia	deletion	found	in	a	Dutch	
family	(--AW).	
Blood	Cells	Mol	Dis.	2010	Aug	15;45(2):133-5.	
Kaufmann	JO,	Phylipsen	M,	Neven	C,	Huisman	W,	van	Delft	P,	Bakker-Verweij	M,	Arkesteijn	SG,	
Harteveld	CL,	Giordano	PC.	Hb	St.	Truiden	[a68(E17)Asn→His]	and	Hb	Westeinde	[a125(H8)
Leu→Gln]:	two	new	abnormalities	of	the	a2-globin	gene.	
Hemoglobin.	2010;34(5):439-44.
Phylipsen	M,	Harteveld	CL,	de	Metz	M,	Gallivan	MV,	Arkesteijn	SG,	Luo	HY,	Chui	DH,	Giordano	
PC.	New	and	known	b-thalassemia	determinants	masked	by	known	and	new	d	gene	defects	[Hb	
A2-Ramallah	or	d6(A3)Glu→Gln,	GAG>>CAG].	
Hemoglobin.	2010;34(5):445-50.
Versteegh	FG,	Arkesteijn	SG,	Bakker-Verweij	M,	Haanappel	K,	van	Delft	P,	Phylipsen	M,	
Kaufmann	JO,	Kok	PJ,	Lansbergen	GW,	Giordano	PC,	Harteveld	CL.	Hb	Boskoop	[HBA2c.112C>T	
p.Pro38Ser]:	a	new	a2	chain	variant	observed	in	a	Morrocan	family.	
Hemoglobin.	2011;35(2):97-102.
Phylipsen	M,	Chaibunruang	A,	Vogelaar	IP,	Balak	JR,	Schaap	RA,	Ariyurek	Y,	Fucharoen	S,	den	
Dunnen	JT,	Giordano	PC,	Bakker	E,	Harteveld	CL.	Fine-tiling	array	CGH	to	improve	diagnostics	
for	a-	and	b-thalassemia	rearrangements.	
Hum	Mutat.	2012	Jan;33(1):272-80
Phylipsen	M,	Traeger-Synodinos	J,	van	der	Kraan	M,	van	Delft	P,	Bakker	G,	Geerts	M,	Kanavakis	
E,	Stamoulakatou	A,	Karagiorga	M,	Giordano	PC,	Harteveld	CL.	A	novel	a0	-thalassemia	deletion	
in	a	Greek	patient	with	HbH	disease	and	β-thalassemia	trait.	
Eur	J	Haematol.	2012	Apr;88(4):356-62.
Harteveld	CL,	Ponjee	G,	Bakker-Verweij	M,	Arkesteijn	SG,	Phylipsen	M,	Giordano	PC.	Hb	
Haaglanden:	a	new	nonsickling	b7Glu>Val	variant.	Consequences	for	basic	diagnostics,	
screening,	and	risk	assessment	when	dealing	with	HbS-like	variants.	
Int	J	Lab	Hematol.	2012	Apr	11.	
Phylipsen	M,	Yamsri	S,	Treffers	EE,	Jansen	DT,	Kanhai	WA,	Boon	EM,	Giordano	PC,	Fucharoen	
S,	Bakker	E,	Harteveld	CL.	Non-invasive	prenatal	diagnosis	of	beta-thalassemia	and	sickle-cell	
disease	using	pyrophosphorolysis-activated	polymerization	and	melting	curve	analysis.	
Prenat	Diagn.	2012	Jun;32(6):578-87.	
Tritipsombut	J,	Phylipsen	M,	Viprakasit	V,	Chalaow	N,	Sanchaisuriya	K,	Giordano	PC,	Fucharoen	
S,	Harteveld	CL.	A	single-tube	multiplex	gap-PCR	for	the	detection	of	eight	b-globin	gene	cluster	
deletions	common	in	Southeast	Asia.	
Hemoglobin.	2012;36(6):571-80.
203
